Author: Mark Newman

Share

Eradicating Racism in Endocrinology: The Time Is Always Now

Mark Headshot In January, the Endocrine Society’s Committee on Diversity and Inclusion and Advocacy and Public Outreach Core Committee joined together to publish “Eradicating Racism in Endocrinology: An Endocrine Society Policy Perspective” in The Journal of Clinical Endocrinology & Metabolism. In this paper, the Endocrine Society formally calls for policies to address racial and ethnic inequities in...
Share

Shock to the System: Pediatric Type 1 Diabetes Patients and Trauma

A new study seems to suggest that while trauma and post-traumatic stress syndrome are common in kids with type 1 diabetes, they have little to no impact on their diabetes self-management. However surprising this finding may be to researchers, it further stresses the need for multidisciplinary teams to care for these patients. Children suffering traumatic...
Share

Cortisol Excess: Unsafe at Any Level?

A new study finds that even low levels of the “mild cortisol excess” associated with adrenal incidentalomas can increase cardiometabolic risk.   Benign tumors on adrenal glands may not be so benign when it comes to patients’ overall health, according to the largest study to date on the topic. An international consortium of researchers found...
Share

More Questions Than Answers: Q&A with Terry J. Smith, MD

Smith_Laureate2022 Endocrine News talks to Terry J. Smith, MD, the 2022 Gerald D. Aurbach Laureate for Outstanding Translational Research, who discusses his career focusing on Graves disease, the pharmaceutical he helped develop, and what advice he has for young researchers. Early in medical school, Terry J. Smith, MD, had more questions about thyroid disease than his...
Share

Will Charlton Named CMO at Spruce Biosciences, Inc.

Will Charlton (002) Endocrine Society member Will Charton, MD, MAS, has been appointed chief medical office at Spruce Biosciences, Inc., a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders with significant unmet medical need. Charlton, a board-certified pediatric endocrinologist with over 15 years of clinical research experience in industry and academia, will...